IDEAYA Biosciences (IDYA) Stock Price, Quote, News & History | Benzinga

SPY770.84+0.23%QQQ721.79+0.58%BTC/USD83,686.36+0.90%DIA524.75+0.07%GLD379.08+0.38%TLT80.41+0.34%

IDEAYA Biosciences Inc (IDYA) Stock Price, Quote, News & History

IDYANASDAQ

Trade with Public

Trade with Public

$35.66

0.300.85%

Last update: Oct 21, 9:40 AM

$35.36

N/A

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$35.43

Close

-

Volume / Avg.

14.00K / 784.14K

Day Range

$35.35 - $35.71

52 Wk Range

26.81 - 42.68

Market Cap

$3.44B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

34

Short Interest

11.05%

Days to Cover

8.43

Recent IDEAYA Biosciences, Inc. News

Mission Produce Posts Downbeat Q2 Earnings, Joins Ideaya Biosciences, Perrigo And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

U.S. stock futures higher, Nasdaq up 200 points. Mission Produce (NASDAQ: AVO) shares down on weak earnings. Other stocks also down in pre-market.

Avi Kapoor

Why Nuvalent Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket

GSK to acquire Nuvalent for $10.6 billion, shares rise 38.2%. Other gainers include CCTG, CHAI, RGNT, MTEN, NCRA, ZTG, EPSM, DBI, APLD. Losers include BYAH, NOTV.

Avi Kapoor

Leggett & Platt, Allogene Therapeutics, Revolution Medicines And Other Big Stocks Moving Higher On Monday

U.S. stocks were mixed on Monday, with the Dow Jones falling over 200 points. Leggett & Platt rose on news of being acquired by Somnigroup.

Avi Kapoor

IDEAYA Eye Cancer Trial Data Beats Standard Therapy, Stock Soars

IDEAYA shares rise after darovasertib trial shows progression-free survival benefit in uveal melanoma; NDA filing planned for 2026.

Vandana Singh

Stock Market Today: Dow Futures Fall As Trump Announces Strait Of Hormuz Blockade—Goldman Sachs, Fastenal In Focus (UPDATED)

Editor’s note: The future prices of benchmark tracking ETFs and pre-market prices of stocks have been updated. U.S. stock futures declined on Monday following Friday's mixed close. Futures of major benchmark indices were lower after President Donald Trump announced a blockade of the Strait of Hormuz.

Benzinga Neuro

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-111.66M

Investing Cash Flow (TTM)

-92.74M

Financing Cash Flow (TTM)

362.82M

Free Cash Flow (TTM)

-113.87M

Capital Expenditure (TTM)

-2.21M

Net Change in Cash (TTM)

158.42M

Analyst Trends and Forecast

2

Jul

2

Aug

1

Sep

2

Oct

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$2.61B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

13.51

PB Ratio (TTM)

2.85

Earnings Yield % (TTM)

-5.43%

Earnings Yield % (FWD)

-11.82%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$12.43

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$272.59M

Debt to Equity

0.02

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-